** About Us **
** Our Vision **
Creating a cancer-free world. One person, one discovery at a time.
** Our Mission **
To eradicate cancer from individuals’ lives by creating knowledge and integrating groundbreaking research with excellence in education and patient-centered care
** Overview **
As the Midwest's first and Ohio's only fully dedicated cancer hospital and research institute, The Ohio State University Comprehensive Cancer Center–Arthur G. James Cancer Hospital and Solove Research Institute (OSUCCC–James) is one of the nation's premier cancer centers for the prevention, detection and treatment of cancer.
The OSUCCC–James is one of only 40 centers in the United States designated by the National Cancer Institute a Comprehensive Cancer Center. In addition, the OSUCCC–James is a founding member of the National Comprehensive Cancer Network (NCCN), an alliance of 21 of the world's leading cancer centers that develops clinical practice guidelines to improve the quality and effectiveness of care provided to patients with cancer.
The Ohio State cancer program is part of The Ohio State University, the largest public university in the nation. We are affiliated with The Ohio State University Medical Center, one of the largest and most diverse academic medical centers in the nation and the only academic medical center in central Ohio.
The cancer program at Ohio State encompasses more than 200 comprehensive cancer center members from 13 of the 18 colleges at The Ohio State University and includes physicians from 16 specialties. The OSUCCC–James' singular focus on cancer has led to multiple accomplishments that have changed the standards of care with respect to prevention, diagnosis and treatment, in a way that substantially improves outcomes for cancer patients.
In 2009, The Ohio State University Board of Trustees approved a $1 billion expansion of the cancer hospital and Medical Center facilities, including a new 276-bed* cancer hospital and critical care building. This expansion sets Ohio State apart as a national leader in innovative cancer care by supporting new, high-quality, patient-centered, personalized medicine. The new hospital will have increased capacity to help keep pace with the projected 21 percent growth in admissions during the next decade.
